About Journal of Pharmaceutical Analysis

Journal of Pharmaceutical Analysis

The Journal of Pharmaceutical Analysis is a peer-reviewed, open-access scientific journal published in Xi'an, Shaanxi, on behalf of Xi'an Jiaotong University, with publication through Elsevier. Launched in 2011, it is the official journal of Xi'an Jiaotong University and was described in its early record as the first pharmaceutical analysis journal in English with both ISSN and CN certificates in mainland China. It carries the print ISSN 2095-1779 and the online ISSN 2214-0883, uses the abbreviation J. Pharm. Anal., and appears monthly. Its subject is pharmaceutical analysis in the full sense: how medicines, their ingredients and their breakdown products in the body are identified, measured and judged for quality.

That focus gives the journal a practical importance that goes beyond the laboratory bench. Every medicine that reaches a patient depends on analysis — on methods that can prove what is in a tablet, how much of the active ingredient it contains, whether impurities are present and whether the product will remain stable on the shelf. The Journal of Pharmaceutical Analysis publishes the methods and studies on which that proof rests, from university laboratories in Xi'an and across China and from contributors abroad, in English and open access, so that the work can be read without a subscription barrier.

Origins and launch in 2011

The journal was launched in 2011 by Xi'an Jiaotong University. Its earliest descriptions record that it was published bimonthly at the start by the university, with the cooperation of the Chinese Pharmaceutical Association, and that peer review was conducted under the responsibility of Xi'an Jiaotong University. It has since become a monthly publication. ScienceDirect, Elsevier's platform, presents it as a monthly peer-reviewed open-access journal publishing original research articles, review papers, short communications, news, research highlights and editorials in the field described as the analysis of pharmacy.

Xi'an is a fitting home for such a title. The city in Shaanxi is one of China's historic centres of learning, and Xi'an Jiaotong University is one of the country's major research universities. Anchoring the journal at the university, rather than at a commercial publisher alone, ties its editorial direction to an academic institution, while the Elsevier platform gives its articles international distribution, digital object identifiers and the indexing visibility that a university journal launched in 2011 would need to compete with older Western titles in pharmaceutical analysis.

Publisher, ownership and open-access model

The Journal of Pharmaceutical Analysis is an official journal of Xi'an Jiaotong University, published through Elsevier on ScienceDirect. Copyright and responsibility rest with the university side of the partnership, and the journal's guide for authors notes peer review under the responsibility of Xi'an Jiaotong University. As an open-access title, its articles are freely available to readers, with an article publishing charge supporting publication; ScienceDirect lists an APC of USD 1,950 excluding taxes. That model matters for its field, because analytical methods are most useful when any competent laboratory — including quality-control laboratories in industry and in regulatory settings — can read, check and reproduce them.

Open access also shapes who the journal can serve. A method for measuring a drug in blood plasma, or for detecting an impurity in a traditional medicine, may be needed by a hospital laboratory, a small manufacturer or a researcher in a country without large subscription budgets. Removing the paywall removes one obstacle between the published method and its practical use, while peer review and indexing provide the quality signals that readers use to decide which methods to trust.

Scope: analysis of pharmacy in breadth

ScienceDirect summarises the journal's coverage as broadly including pharmaceutical analysis, analytical techniques and methods, pharmacology, metabolism, drug delivery, cellular imaging and analysis, natural products and biosensing. Its fuller scope statement lists current areas of interest including new techniques and methods in pharmaceutical analysis, the analysis of traditional Chinese medicine, pharmaceutical analysis of complex systems, quality control and methods for biotech drugs, studies of action mechanism and metabolism in the body, quantitative and qualitative analysis in drug screening, tracer analysis in molecular pharmacology, quantitative analysis in biopharmaceutics, and clinical laboratory and bioanalysis work, together with analysis of small drug molecules and pharmaceutical solid materials.

Read together, those headings describe a journal that follows a medicine through its whole life: discovery and screening, formulation and manufacture, quality control, administration to a patient, metabolism inside the body and measurement in clinical samples. Few analytical journals attempt the whole chain, and the breadth explains why the journal's articles range from instrumentation papers to studies of complex herbal prescriptions.

Drug quality control and analytical method development

Quality control and analytical method development sit at the centre of the journal's remit, as the commissioning record for this profile also notes. A quality-control method must do more than produce a number: it must be shown to be accurate, precise, specific and robust enough that another laboratory, on another instrument, obtains the same result. Papers in this area therefore typically present a method — often based on chromatography or spectroscopy — together with its validation, its application to real samples and a discussion of the impurities, degradation products or variations it can detect.

Method development is the creative counterpart of quality control. New instruments, new separation materials and new data-processing approaches continually change what can be measured, at what sensitivity and in how complex a mixture. By publishing new techniques and methods as a named area of interest, the journal provides a home for work that improves the tools themselves, not only for studies that apply existing tools to a new drug. For readers in pharmaceutical industry quality laboratories, that combination — better tools, validated on real products — is the journal's most directly usable content.

Pharmacokinetics, metabolism and bioanalysis

A second major strand is what happens to a drug after it is taken. The journal's scope includes pharmacology and metabolism, quantitative analysis in biopharmaceutics, tracer analysis in molecular pharmacology and clinical laboratory and bioanalysis work, and the seed record for this profile lists pharmacokinetics and metabolomics among its core subjects. Pharmacokinetic studies measure how a drug is absorbed, distributed, metabolised and excreted; bioanalytical methods make those measurements possible in blood and other biological samples, where the drug and its metabolites are present in very small amounts among thousands of interfering substances.

Metabolomics extends that logic from one drug to the whole metabolic profile of a sample. Instead of asking only how much of a compound is present, metabolomic studies ask how the pattern of metabolites changes — after a dose, during a disease or in response to a traditional medicine. Publishing such work alongside conventional bioanalysis places the Journal of Pharmaceutical Analysis at the point where analytical chemistry meets pharmacology and clinical research, and its indexing in PubMed Central reflects that biomedical readership as well as its chemical one.

Traditional Chinese medicines and biologics

The analysis of traditional Chinese medicine is a named priority of the journal, covering medicinal materials, patent medicines, prescriptions and injections. Such products pose some of the hardest problems in pharmaceutical analysis: a single prescription may contain many medicinal plants, each with many constituents, and quality cannot be judged by measuring one marker compound alone. Research published in this area therefore includes fingerprinting approaches, multi-component quantification and the search for quality markers that genuinely reflect a preparation's activity — work illustrated in the journal by studies building authentication and quality-marker strategies for traditional prescriptions.

At the other end of the complexity scale, the journal also covers quality control and methods for biotech drugs — biologics. Protein and other biotechnology products cannot be fully characterised by the methods used for small molecules; their quality depends on structure, modification and biological activity as well as purity. Covering traditional medicines and biologics in the same journal is less paradoxical than it first appears: in both cases the analytical problem is a complex system whose quality must be inferred from careful, multi-dimensional measurement, which is exactly the expertise the journal exists to publish.

Article types and editorial character

ScienceDirect describes the journal as publishing significant original research articles, review papers and short communications, together with news, research highlights and editorials. Original articles carry new methods and new applications; reviews organise fast-moving techniques — a new separation mode, a new mass-spectrometry workflow, a new approach to herbal quality control — for readers who need an entry point; short communications allow a useful method or finding to be reported quickly and concisely. The presence of news, highlights and editorials gives the journal a community function for pharmaceutical analysts, not merely an archival one.

Elsevier's journal insights for the title emphasise a distinguished editorial board as the guarantee that issues contain current work in the field. For a methods journal, editorial judgement has a particular character: referees must judge not only whether a result is interesting, but whether the method is sound, validated and described in enough detail to be reproduced. That reproducibility standard is the quiet discipline behind the journal's contribution to drug quality worldwide.

Indexing, identifiers and discoverability

The journal is indexed in Science Citation Index Expanded (SCIE, also written SCI-Expanded), Scopus, PubMed Central and the Directory of Open Access Journals, and Elsevier's insights page also lists Elsevier BIOBASE, Embase, EBSCOhost, zbMATH Open and Ovid Discovery among its abstracting and indexing services. The seed record for this profile confirms SCI-Expanded, PubMed Central and Scopus. Its identifiers are print ISSN 2095-1779 and online ISSN 2214-0883, and its standard abbreviation is J. Pharm. Anal.

That combination of indexes maps neatly onto its readership: SCIE and Scopus for the chemistry and pharmaceutical-science communities and for university evaluation systems, PubMed Central for biomedical researchers and clinicians who encounter its bioanalysis and pharmacokinetics papers, and DOAJ as the registry signal of a legitimate open-access title. For authors in China and across Asia, publication in an English-language, SCIE-indexed, PubMed Central-visible journal based at a Chinese university offers international visibility without leaving a home editorial community.

Place in Xi'an and in Chinese pharmaceutical science

The Journal of Pharmaceutical Analysis belongs to a wider pattern in contemporary Chinese scholarly publishing: a leading university sponsors an English-language, internationally distributed journal in a field where China has both deep research capacity and large practical needs. China's pharmaceutical industry is one of the world's largest, its traditional-medicine sector requires modern analytical standards, and its universities train very large numbers of analytical chemists and pharmacists. A journal based in Xi'an that publishes validated methods, quality studies and bioanalysis in open access serves all three constituencies at once.

Within this directory's classification it is listed as a magazine — a periodical — from Xi'an, Shaanxi, in the scientific and professional press. Its profile here should be read in that spirit: not as a popular magazine for general readers, but as a specialist journal whose readers are researchers, quality professionals and clinicians, and whose influence is measured in methods adopted, standards informed and citations accumulated rather than in newsstand sales.

Why the Journal of Pharmaceutical Analysis matters

The journal matters because analysis is the part of pharmaceutical science that turns claims into evidence. A new drug, a traditional prescription or a biologic product is only as trustworthy as the measurements that describe it, and since 2011 the Journal of Pharmaceutical Analysis has provided a peer-reviewed, open-access, internationally indexed place — rooted at Xi'an Jiaotong University in Xi'an — where those measurements are published, criticised and improved. Its coverage of drug quality control, analytical method development, pharmacokinetics, metabolomics and the analysis of traditional Chinese medicines and biologics reflects the real breadth of that task, and its presence in SCI-Expanded, PubMed Central and Scopus ensures the work reaches the laboratories and clinics that need it.